financetom
Business
financetom
/
Business
/
Samsung Electronics Completes Acquisition of Xealth, Accelerating Connected Care
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Samsung Electronics Completes Acquisition of Xealth, Accelerating Connected Care
Oct 17, 2025 5:23 AM

Building a bridge between wellness and clinical care, Samsung and Xealth will create a health ecosystem that helps clinicians and patients leverage wearable devices to help inform care

SEOUL, South Korea & SEATTLE--(BUSINESS WIRE)--

Samsung Electronics Co., Ltd. today announced that it has acquired Xealth, the leading digital health platform that brings diverse digital tools and care programs that benefit patients and providers. The combined entity will help advance Samsung’s vision for connected care, taking a seamless and holistic approach to preventative care to as many people as possible.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251017568944/en/

Originally announced in July, Samsung’s acquisition of Xealth will help unify fragmented health information, making it more accessible to clinicians and empowering individuals in controlling their own health. Millions of people use wearable technology daily to keep track of their wellness journey, and that data is typically separate from the health records maintained by clinicians and health systems, sometimes leading to missed insights and delayed care.

Combining Samsung’s advanced wearable technology and Xealth’s digital health platform will unite this information for the clinician, linking home health monitoring and clinical decision-making to better support the provider-patient relationship – even when outside the facility. Connecting wearables into clinician workflows at this scale can benefit clinical trials, preventative care, and health monitoring efforts.

“Samsung’s leadership in innovative technologies combined with Xealth’s deep expertise and extensive healthcare network will deliver seamless connected care at scale,” said Dr. Hon Pak, Senior Vice President and Head of Digital Health Team, Mobile eXperience Business, at Samsung Electronics. “Samsung and the Xealth team will engage, learn, and support health systems, consumers and digital health partners in creating a healthcare ecosystem that aims to improve the health of everyone.”

Samsung is committed to making digital health tools accessible to all through relentless technology innovation and a boundless device ecosystem. Its diverse product portfolio helps bring better context and personalization around healthcare. Combining Samsung with Xealth will provide a seamless experience across wellness and medical care and bring hyper-personalized, preventative care.

“Our mission from day one has been to strengthen the bond between medical care teams and their patients through familiar technologies,” said Mike McSherry, CEO and co-founder of Xealth. “That driving force is supported and propelled through Samsung in a way that will bring truly connected care and add fresh context to the patient experience in a way not possible before. Together with Samsung and our network of healthcare leaders, we will design a bridge between home health monitoring and clinical decision-making, with provider workflows and the patient-provider relationship at the core. We are excited to join forces with Samsung.”

Samsung’s acquisition of Xealth has completed all customary closing conditions, including required regulatory approvals. Xealth will continue operations under its existing brand and its leadership team remains in place.

Xealth, spun out of Providence health system, combines multiple digital health solutions into a single user interface and platform, giving healthcare providers a more complete picture of their patients, and enabling real-time monitoring, continuous engagement and smarter decision making. Xealth acts as an orchestration layer that gives health systems control over how they manage, filter, and use data. The company currently has a network of more than 500 U.S. hospitals, including Advocate Health and Banner Health, and more than 70 digital health solution partners, which will gain access to Samsung’s platform and enhance the connected care platform.

About Samsung Electronics Co., Ltd.

Samsung inspires the world and shapes the future with transformative ideas and technologies. The company is redefining the worlds of TVs, digital signage, smartphones, wearables, tablets, home appliances and network systems, as well as memory, system LSI and foundry. Samsung is also advancing medical imaging technologies, HVAC solutions and robotics, while creating innovative automotive and audio products through Harman. With its SmartThings ecosystem, open collaboration with partners, and integration of AI across its portfolio, Samsung delivers a seamless and intelligent connected experience. For the latest news, please visit the Samsung Newsroom at news.samsung.com.

About Xealth

Xealth created the leading digital health platform helping health systems deliver connected, personalized care at scale. Embedded in the EHR, it enables clinicians to prescribe, automate, and measure the impact of digital tools—including apps, services, and wearable data—within existing workflows. Now part of Samsung’s connected care vision, Xealth enhances decision-making, reduces friction, and supports enterprise-wide digital health strategies. Trusted by more than 500 hospitals and 70+ solution partners, Xealth provides a scalable foundation for delivering connected, personalized, and preventative care—empowering health systems to drive outcomes, engagement, and operational efficiency while advancing digital transformation.

For more information, visit www.xealth.com or follow us on LinkedIn or X.

Source: Samsung Electronics Co.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Relay Therapeutics to Collaborate With Pfizer to Evaluate Metastatic Breast Cancer Treatment
Relay Therapeutics to Collaborate With Pfizer to Evaluate Metastatic Breast Cancer Treatment
Jun 5, 2024
05:04 PM EDT, 06/05/2024 (MT Newswires) -- Relay Therapeutics ( RLAY ) unveiled late Wednesday a clinical trial collaboration with Pfizer ( PFE ) to evaluate a treatment for patients with PI3Ka-mutated, HR+, HER2- metastatic breast cancer. The partnership is evaluating atirmociclib, Pfizer's ( PFE ) investigative selective-CDK4 inhibitor, in combination with RLY-2608 and fulvestrant, Relay Therapeutics ( RLAY )...
Ventyx Biosciences Preclinical Study of Obesity Control Candidate Shows Positive Results
Ventyx Biosciences Preclinical Study of Obesity Control Candidate Shows Positive Results
Jun 5, 2024
05:04 PM EDT, 06/05/2024 (MT Newswires) -- Ventyx Biosciences ( VTYX ) said Wednesday that VTX3232 effectively reduced body weight and food intake during two preclinical diet-induced obesity mouse model studies. The results show that the drug decreased liver steatosis and triglycerides, and also had greater benefits in combination with semaglutide, according to the company. The company said it plans...
Thermo Fisher Scientific Insider Sold Shares Worth $11,374,358, According to a Recent SEC Filing
Thermo Fisher Scientific Insider Sold Shares Worth $11,374,358, According to a Recent SEC Filing
Jun 5, 2024
05:05 PM EDT, 06/05/2024 (MT Newswires) -- Marc N Casper, Director, Chairman & CEO, on June 03, 2024, sold 20,000 shares in Thermo Fisher Scientific ( TMO ) for $11,374,358. Following the Form 4 filing with the SEC, Casper has control over a total of 183,724 shares of the company, with 123,816 shares held directly and 59,908 controlled indirectly. SEC...
Kyndryl Holdings Insider Sold Shares Worth $802,244, According to a Recent SEC Filing
Kyndryl Holdings Insider Sold Shares Worth $802,244, According to a Recent SEC Filing
Jun 5, 2024
05:04 PM EDT, 06/05/2024 (MT Newswires) -- Vineet Khurana, Senior Vice President & Global Controller, on June 03, 2024, sold 30,430 shares in Kyndryl Holdings ( KD ) for $802,244. Following the Form 4 filing with the SEC, Khurana has control over a total of 78,722 shares of the company, with 78,722 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1867072/000112760224017950/xslF345X03/form4.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved